Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
China Starch Holdings Limited ( (HK:3838) ) has issued an update.
China Starch Holdings Limited, through its subsidiary Golden Corn Biotech, has engaged in multiple machinery acquisition contracts with Shanghai Senon and Qidong Senon, totaling approximately RMB51.5 million, to support production expansion. The latest acquisition by another subsidiary, DGC, involves a RMB20.6 million contract with Shanghai Senon, which, when aggregated with previous contracts, constitutes a discloseable transaction under the Hong Kong Listing Rules, indicating strategic growth and investment in production capabilities.
More about China Starch Holdings Limited
China Starch Holdings Limited operates in the biotechnology sector, focusing on the production and expansion of machinery for industrial applications through its subsidiaries.
Average Trading Volume: 12,638,658
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.1B
Learn more about 3838 stock on TipRanks’ Stock Analysis page.